Text Size

Three-year follow-up of a novel aqueous humor microshunt

Batlle J.F., Fantes F., Riss I., Pinchuk L., Alburquerque R., Kato Y.P., Arrieta E., Peralta A.C., Palmberg P., Parrish R.K., II, Weber B.A., Parel J.-M.


  • 2016
  • Journal of Glaucoma
View publication
  • Therapeutic Area

    Glaucoma

  • Categories

    Clinical development

  • Affiliations

    Centro Laser, Santo Domingo, Dominican Republic; Ophthalmic Biophysics Center Bascom Palmer Eye Institute, University of MiamiMiller School of Medicine, United States; Anne Bates Leach Eye Hospital, University of Miami, United States; InnFocus Inc., Miami, FL, United States; Pôle Ophtalmologique de la Clinique Mutualiste, Pessac, Cedex, France

Related Publications

Associations between Clustered Visual Field Progression and Locations of Disc Hemorrhages in Glaucoma: A Three-year Prospective Study

Akagi T.; Fukuchi T.; Higashide T.; Udagawa S.; Ohkubo S.; Sugiyama K.; Tanihara H.; Araie M.; Tomita G.; Matsumoto C.; Tomidokoro A.; Hangai M.; Kawata H.; Inai M.; Tanaka Y.; SVF Prospector Study Group


Proteome-Wide Analysis of Autoantibodies in Open-Angle Glaucoma in Japanese Population: A Pilot Study

Takada N.; Ishikawa M.; Sato K.; Kunikata H.; Ninomiya T.; Hanyuda A.; Fukuda E.; Yamaguchi K.; Ono C.; Kirihara T.; Shintani C.; Tsusu C.; Osanai A.; Goshima N.; Izumi Y.; Zorumski C.F.; Nakazawa T.


Bioequivalence of Preservative-free and Preserved Omidenepag Isopropyl (OMDI) 0.002% Ophthalmic Solutions in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Results from the Phase 3 DAISY Study

Aihara M.; Lu F.; Ikeda T.; Odani-Kawabata N.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022